Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.11

+$0.07 (+1.39%)

At close: Nov 2, 2026, 4:00 PM ET

$5.00

-$0.04 (-0.79%)

Pre-market: Nov 2, 2026, 9:25 AM ET

TTM Period Ending	Q2 2025 Dec 31, 2025	Q4 2024 Jun 30, 2025
Net Income	-9.67M	-9.94M
Depreciation & Amortization	2.85M	799.14K
Stock-Based Compensation	n/a	n/a
Other Working Capital	n/a	n/a
Other Non-Cash Items	10.22M	10.18M
Deferred Income Tax	n/a	n/a
Change in Working Capital	-5.34M	-1.34M
Operating Cash Flow	-1.93M	-302.73K
Capital Expenditures	-643.31K	-518.8K
Cash Acquisitions	-9.61M	-9.96M
Purchase of Investments	n/a	n/a
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	-10.25M	-10.48M
Debt Repayment	-2.47M	-3.06M
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	-661.03K	649.21K
Financial Cash Flow	6.27M	6.98M
Net Cash Flow	-5.64M	-3.91M
Free Cash Flow	-2.58M	-821.53K
Adj. Free Cash Flow	-2.58M	-821.53K
Maintenance CapEx	n/a	n/a
Growth CapEx	n/a	n/a
Owner Earnings	n/a	n/a